www.camurus.com Open in urlscan Pro
108.141.162.121  Public Scan

Form analysis
1 forms found in the DOM

/search/

<form class="_placeholder" action="/search/">
  <input type="text" placeholder="Search" aria-label="" class="_searchfield" name="q" value="" autocomplete="off">
  <button class="_searchsubmit">Search</button>
  <div class="_instantsearch" data-nohits="No results found"></div>
</form>

Text Content

Skip to main contentSkip to navigationSkip to search
   
English
EnglishSvenska

Search



 * About us
   * About us
   
   * Contact us
   
   * Our commitment
   * Business model
   * Board of directors
   * Management team
     * Alberto M. Pedroncelli
   * Code of Conduct
 * Science
   * Science
   
   * 
   
   * Products
   * R&D pipeline
   * Technology
 * Disease areas
   * Disease areas
   
   * Read Will's story
   
   * Opioid dependence
   * Acromegaly
   * Neuroendocrine tumors
   * Polycystic liver disease
 * Sustainability
   * Sustainability
   
   * 
   
   * Patients
     * Clinical trials
   * People
   * Planet
     * Transitionplan
   * Responsible business
   * Governing documents
 * Investors
   * Investors
   
   * 
   
   * The share
   * Press releases
   * Events and presentations
   * Financial calendar
   * Financial reports
   * Analysts
   * Corporate governance
     * Committees
     * Remuneration
     * General meetings
     * Auditors
     * Incentive programs
     * Articles of association
     * Nomination Committee
     * AGM
   * General meetings
   * Investor contact
   * Subscription
 * Partnering
 * Media
   * Media
   
   * 
   
   * Press releases
   * Media contact
   * Media archive
 * Career
 * Contact


DELIVERING BETTER TREATMENTS

Camurus is committed to improving the lives of patients
with severe and chronic diseases

Read more


UPDATES


LATEST NEWS

All press releases

30 September 2024


CHANGE IN NUMBER OF SHARES AND VOTES IN CAMURUS

Press release Regulatory
20 September 2024


EMA POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION TO CAMURUS’ OCTREOTIDE SC DEPOT
FOR THE TREATMENT OF POLYCYSTIC LIVER DISEASE

Press release
19 September 2024


EXERCISE IN CAMURUS’ EMPLOYEE STOCK OPTIONS PROGRAM 2021/2024

Press release

All press releases

Disease areas


FOCUS ON SEVERE AND CHRONIC DISEASES

Developing treatments for diseases within the central nervous system, rare
diseases, endocrinology, oncology and supportive care

Learn more on disease areas

Events


UPCOMING EVENTS


See all events

 * 07 Nov
   
   
   INTERIM REPORT JANUARY-SEPTEMBER 2024
   
   The interim report January-September is published on 7 November, 2024.
   
   Add to calendar

 * 19 Nov
   
   
   SEB HEALTHCARE SEMINAR
   
   Camurus' President & CEO Fredrik Tiberg is presenting at this conference in
   Stockholm, 19 Novemer. The presentation can be seen by the conference
   participants. More information will follow closer to the event.
   
   Add to calendar

 * 20 Nov
   
   
   JEFFERIES LONDON HEALTHCARE CONFERENCE
   
   Camurus’ President & CEO Fredrik Tiberg is presenting at this conference in
   London, 20 November. The presentation can be seen by the conference
   participants. More information will follow closer to the event.
   
   Add to calendar





Latest financial report


CAMURUS’ INTERIM REPORT SECOND QUARTER 2024

16 July 2024

 * Report Camurus’ Interim Report Second Quarter 2024
 * Presentation Camurus’ Interim Report Second Quarter 2024
 * Audiocast Camurus’ Interim Report Second Quarter 2024

Go to report archive



Products




ADDRESSING IMPORTANT UNMET MEDICAL NEEDS

Learn about our products

Stories




LIVING WITH OPIOID DEPENDENCE

Read Daniel's story


ANNUAL REPORT 2023

Camurus Annual Report 2023 (pdf)

Camurus Annual Report 2023 (ESEF/ZIP) (In Swedish)

Pipeline


DIVERSIFIED PIPELINE WITH LARGE POTENTIAL

Camurus’ innovative product candidates are designed to address important unmet
medical needs, with the potential to make significant difference in the daily
life of patients by improving treatment outcomes, quality of life, and long-term
recovery.

See pipeline

sustainability


SUSTAINABLE SOLUTIONS FOR A HEALTHIER WORLD

Ensuring the long-term successful development of our business – for the benefit
of patients, healthcare systems, employees and shareholders.

Learn more






QUICK LINKS

 * Contact
 * About us
 * Pipeline
 * Products


INVESTORS

 * Press releases
 * Financial reports
 * IR contact


ADDRESS

Camurus AB
Ideon Science Park
SE-223 70 Lund, Sweden




 * Terms of Use
 * Privacy notice
 * Cookie policy

Camurus AB - all rights reserved


This website uses cookies to provide the best possible user experience. By
accepting you consent to cookies being used. If you want to find out more or
disable cookies, please click here.

Reject Accept all